Atomistry » Chlorine » PDB 8tg4-8tsz » 8tqt
Atomistry »
  Chlorine »
    PDB 8tg4-8tsz »
      8tqt »

Chlorine in PDB 8tqt: MPI52 Bound to Mpro of Sars-Cov-2

Enzymatic activity of MPI52 Bound to Mpro of Sars-Cov-2

All present enzymatic activity of MPI52 Bound to Mpro of Sars-Cov-2:
3.4.22.69;

Protein crystallography data

The structure of MPI52 Bound to Mpro of Sars-Cov-2, PDB code: 8tqt was solved by L.R.Blankenship, W.R.Liu, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 44.84 / 1.65
Space group I 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 54.34, 80.76, 86.144, 90, 97.2, 90
R / Rfree (%) 22.3 / 23.9

Chlorine Binding Sites:

The binding sites of Chlorine atom in the MPI52 Bound to Mpro of Sars-Cov-2 (pdb code 8tqt). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the MPI52 Bound to Mpro of Sars-Cov-2, PDB code: 8tqt:

Chlorine binding site 1 out of 1 in 8tqt

Go back to Chlorine Binding Sites List in 8tqt
Chlorine binding site 1 out of 1 in the MPI52 Bound to Mpro of Sars-Cov-2


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of MPI52 Bound to Mpro of Sars-Cov-2 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl401

b:73.6
occ:1.00
CL1 A:K2X401 0.0 73.6 1.0
C6 A:K2X401 1.8 43.7 1.0
C7 A:K2X401 2.8 42.1 1.0
C5 A:K2X401 2.8 45.2 1.0
ND2 A:ASN142 3.8 47.9 1.0
C21 A:K2X401 3.9 34.0 1.0
C2 A:K2X401 4.1 40.1 1.0
C4 A:K2X401 4.1 44.1 1.0
O38 A:K2X401 4.1 34.7 1.0
CG A:ASN142 4.1 42.1 1.0
C22 A:K2X401 4.2 33.4 1.0
CB A:ASN142 4.3 38.4 1.0
C3 A:K2X401 4.6 43.2 1.0
OD1 A:ASN142 4.8 39.3 1.0

Reference:

L.R.Blankenship, W.R.Liu. MPI52 Bound to Sars-Cov-2 Mpro To Be Published.
Page generated: Sun Jul 13 14:30:52 2025

Last articles

Fe in 2Y37
Fe in 2XZ0
Fe in 2Y34
Fe in 2XZ1
Fe in 2Y0I
Fe in 2XYK
Fe in 2XVX
Fe in 2XVY
Fe in 2XVZ
Fe in 2XV1
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy